Tiersma, J.F.; Evers, B.; Bakker, B.M.; Jalving, M.; de Jong, S.
Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities. Int. J. Mol. Sci. 2022, 23, 3745.
https://doi.org/10.3390/ijms23073745
AMA Style
Tiersma JF, Evers B, Bakker BM, Jalving M, de Jong S.
Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities. International Journal of Molecular Sciences. 2022; 23(7):3745.
https://doi.org/10.3390/ijms23073745
Chicago/Turabian Style
Tiersma, Jiske F., Bernard Evers, Barbara M. Bakker, Mathilde Jalving, and Steven de Jong.
2022. "Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities" International Journal of Molecular Sciences 23, no. 7: 3745.
https://doi.org/10.3390/ijms23073745
APA Style
Tiersma, J. F., Evers, B., Bakker, B. M., Jalving, M., & de Jong, S.
(2022). Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities. International Journal of Molecular Sciences, 23(7), 3745.
https://doi.org/10.3390/ijms23073745